MenoPatch, a new transdermal skin patch developed by students at Carle Illinois College of Medicine, just took home the top prize at this year’s Founders Forge 2024. That event brings together a wide variety of innovative ideas and projects and celebrates them as part of the latest and greatest things to be developed at the University of Illinois. We have some of the best and brightest right here in our community, and these students are developing something that could change the lives of millions of women.
A Carle Illinois College of Medicine innovation aimed at personalizing hormone replacement therapy for women experiencing menopausal symptoms has earned the top honors at Founders Forge 2024, the Midwest’s largest student-run startup conference. The product under development, MenoPatch, is the work of CI MED physician-innovators who say their solution could revolutionize menopause care for millions of women. They plan to use their winnings to launch a startup company (Equilocalm) to bring their product to market.
MenoPatch is a transdermal skin patch that delivers personalized dosages of hormone replacement therapy to patients experiencing menopausal symptoms. Similar to a nicotine patch, it provides patients with a needleless, user-friendly, and effective solution for delivering hormone therapy to manage menopausal symptoms. MenoPatch differs from other patches by incorporating mechanisms to allow dose modification on the fly with a single patch.
